Showing results (11-20 of 154) with videos related to
Sort By:
Pageof 16
Expert Opinion on Pharmacotherapy|February 12, 2024
Parkinson's disease psychosis management: an evidence based, experience informed, pragmatic approachJoseph H FriedmanMovement Disorders : Official Journal of the Movement Disorder Society|December 5, 2002
Presumed rapid eye movement behavior disorder in Machado-Joseph disease (spinocerebellar ataxia type 3)Joseph H FriedmanAnnals of Internal Medicine|September 2, 2024
In early Parkinson disease, daily subcutaneous lixisenatide reduced motor disability progression at 12 moJoseph H FriedmanRhode Island Medical Journal (2013)|April 3, 2020
Subjective Memory Impairment and Subjective Cognitive Improvement: Role for D-C2H5OH (Deuterated Ethyl Alcohol)? Results of a Double-Blind, Crossover TrialJoseph H FriedmanParkinsonism & Related Disorders|July 31, 2017
Dementia with Lewy Bodies and Parkinson Disease Dementia: It is the Same Disease!Joseph H FriedmanClinical Neuropharmacology|July 14, 2018
Pimavanserin for Psychotic Symptoms in People With Parkinsonism: A Second Chart ReviewJoseph H FriedmanNeurology|August 23, 2006
Atypical antipsychotics in the elderly with Parkinson disease and the "black box" warningJoseph H FriedmanThe Journal of Clinical Psychiatry|June 11, 2004
Historical perspective on movement disordersJoseph H FriedmanClinical Neuropharmacology|June 17, 2017
A Retrospective Study of Pimavanserin Use in a Movement Disorders ClinicJoseph H FriedmanPageof 16